| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.5 | 9e-40 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.32 | 2e-19 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.45 | 8e-19 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.33 | 1e-17 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.44 | 2e-16 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-15 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.29 | 7e-15 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-14 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.32 | 1e-09 |